Unable to insert the jada system [device use issue].Case narrative: this initial spontaneous report originating from the united states was received from a physician referring to a non-pregnant female patient of unknown age.The patient's concurrent condition included hospitalization.The patient's medical history included pregnancy and had scheduled caesarean section.The patient's concomitant medications were not reported.This report concerns 1 patient and 1 device.On (b)(6) 2023, the patient was inserted with vacuum-induced hemorrhage control system (jada system) via intravaginal route for hemorrhage (postpartum haemorrhage) by the physician.The physician stated that she was unable to insert the vacuum-induced hemorrhage control system (jada system) (device use issue) stating she felt the patient was not dilated enough and that the cervix was thin, and she was afraid she would tear it.The patient's hospitalization was prolonged due to the event.On (b)(6) 2023, therapy with vacuum-induced hemorrhage control system (jada system) was discontinued.The patient sought medical attention and she was stable now.No product quality complaint (pqc) reported.The vacuum-induced hemorrhage control system (jada system) was not available for inspection as it was discarded.For vacuum-induced hemorrhage control system (jada system) lot number and serial number were unknown.Medical device reporting criteria: serious injury fda code: (health effects - health impact per annex f): 4648 insufficient information (there is not yet enough information available to classify the health impact) fda code: (health effects - health impact per annex f): 4641 patient required an unforeseen medical intervention, excluding surgery, which was not on the original treatment plan.When the lot number is unknown, a technical investigation of the specific manufacturing process which includes review of records associated with a known lot number cannot be performed.
|